Peer Review reports
From: Indoleamine 2,3 dioxygenase (IDO) level as a marker for significant coronary artery disease
Original Submission | ||
---|---|---|
9 Sep 2020 | Submitted | Original manuscript |
1 Oct 2020 | Reviewed | Reviewer Report |
3 Oct 2020 | Reviewed | Reviewer Report |
1 Nov 2020 | Author responded | Author comments - Nattawut Wongpraparut |
Resubmission - Version 2 | ||
1 Nov 2020 | Submitted | Manuscript version 2 |
2 Nov 2020 | Reviewed | Reviewer Report |
20 Nov 2020 | Reviewed | Reviewer Report |
15 Mar 2021 | Reviewed | Reviewer Report |
26 Mar 2021 | Reviewed | Reviewer Report |
29 Mar 2021 | Reviewed | Reviewer Report |
1 May 2021 | Author responded | Author comments - Nattawut Wongpraparut |
Resubmission - Version 3 | ||
1 May 2021 | Submitted | Manuscript version 3 |
3 May 2021 | Reviewed | Reviewer Report |
4 May 2021 | Reviewed | Reviewer Report |
10 May 2021 | Reviewed | Reviewer Report |
21 May 2021 | Reviewed | Reviewer Report |
25 May 2021 | Author responded | Author comments - Nattawut Wongpraparut |
Resubmission - Version 4 | ||
25 May 2021 | Submitted | Manuscript version 4 |
1 Jun 2021 | Reviewed | Reviewer Report |
1 Jun 2021 | Reviewed | Reviewer Report |
2 Jun 2021 | Reviewed | Reviewer Report |
23 Jun 2021 | Author responded | Author comments - Nattawut Wongpraparut |
Resubmission - Version 5 | ||
23 Jun 2021 | Submitted | Manuscript version 5 |
Publishing | ||
24 Jun 2021 | Editorially accepted | |
26 Jul 2021 | Article published | 10.1186/s12872-021-02140-0 |
You can find further information about peer review here.